COMPANY
Neuronascent
Timeline
- Trial start Phase 1: Phase1a, Dose-escalation Study of NNI-362 in Healthy Aged Volunteers source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT04074837 | Phase1a, Dose-escalation Study of NNI-362 in Healthy Aged Volunteers | Phase 1 | Completed | Aug 1, 2019 | Jul 31, 2021 (actual) |
NIH awards 7
- NIH award 3U01AG082687-02S1 FY2024: $350,000 awarded for that fiscal year; activity U01 (OTHER_NIH); PI KELLEHER-ANDERSSON, JUDITH A; recipient as written: NEURONASCENT, INC., CLARKSVILLE, MD. Completion of Non-clini source ↗
- NIH award 5U01AG082687-02 FY2024: $2,093,556 awarded for that fiscal year; activity U01 (OTHER_NIH); PI KELLEHER-ANDERSSON, JUDITH A; recipient as written: NEURONASCENT, INC., CLARKSVILLE, MD. Completion of Non-clini source ↗
- NIH award 1U01AG082687-01 FY2023: $2,100,000 awarded for that fiscal year; activity U01 (OTHER_NIH); PI KELLEHER-ANDERSSON, JUDITH A; recipient as written: NEURONASCENT, INC., CLARKSVILLE, MD. Completion of Non-clini source ↗
- NIH award 3R01AG056561-02S2 FY2021: $246,631 awarded for that fiscal year; activity R01 (OTHER_NIH); PI KELLEHER-ANDERSSON, JUDITH A; recipient as written: NEURONASCENT, INC., CLARKSVILLE, MD. Neuron regenerative the source ↗
- NIH award 3R01AG056561-02S1 FY2019: $263,516 awarded for that fiscal year; activity R01 (OTHER_NIH); PI KELLEHER-ANDERSSON, JUDITH A; recipient as written: NEURONASCENT, INC., CLARKSVILLE, MD. Neuron regenerative the source ↗
- NIH award 5R01AG056561-02 FY2019: $692,120 awarded for that fiscal year; activity R01 (OTHER_NIH); PI KELLEHER-ANDERSSON, JUDITH A; recipient as written: NEURONASCENT, INC., CLARKSVILLE, MD. Neuron regenerative thera source ↗
- NIH award 1R01AG056561-01A1 FY2018: $1,575,691 awarded for that fiscal year; activity R01 (OTHER_NIH); PI KELLEHER-ANDERSSON, JUDITH A; recipient as written: NEURONASCENT, INC., CLARKSVILLE, MD. Neuron regenerative t source ↗